Skip to main content
Skip to main content
USNA logo

USANA Health Sciences, Inc. (USNA)

$21.56 +$0.05 (+0.23%) |Strong · 78
Bottom line: STRONG BUY — our Council read (78/100) and AI Score (78/100) broadly agree.
MCap: $398.06M| P/E Ratio: 45.0| Vol: 43.3K| Target: $39.00 (+80.9%)| 52-wk range: $16.60 – $38.32
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

USANA Health Sciences, Inc. (USNA) trades at $21.56 with AI Score 78/100 (Grade A). USANA Health Sciences, Inc. develops, manufactures, and sells nutritional and personal care products. Market cap: $398.06M, Sector: Consumer defensive.

Price live · AI analysis from May 9, 2026
USANA Health Sciences, Inc. develops, manufactures, and sells nutritional and personal care products. The company operates primarily through direct sales in the Asia Pacific, the Americas, and Europe.

USNA stock analysis for 2026: Analysts have set a consensus price target of $39.00 for USANA Health Sciences, Inc., suggesting 80.9% upside from the current price of $21.56. The AI MoonshotScore is 78/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
STRONG BUY 78/100 · A

USNA: 1/1 perspectives are bullish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

USANA Health Sciences, Inc. (USNA) Consumer Business Overview

CEOKevin G. Guest
Employees1700
HeadquartersSalt Lake City, UT, US
IPO Year1994

USANA Health Sciences, Inc. develops and distributes science-based nutritional and personal care products through direct sales. The company's key differentiators include its focus on high-quality ingredients, proprietary formulations, and a global distribution network, positioning it within the competitive packaged foods sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 9, 2026

What Is the Investment Thesis for USNA?

USANA Health Sciences, Inc. presents a mixed investment thesis. The company's high gross margin of 76.7% indicates strong pricing power and efficient production. However, a low profit margin of 1.0% raises concerns about operational efficiency and cost management. The company's direct sales model offers growth potential in emerging markets, particularly in the Asia Pacific region. Key catalysts include expanding product lines and strategic partnerships. Potential risks include regulatory scrutiny, competition from established players, and reliance on its direct sales network. Investors should closely monitor sales growth, profitability trends, and regulatory developments.

Based on FMP financials and quantitative analysis

USNA Key Highlights

  • Market capitalization of $398.06M reflects its current valuation in the packaged foods sector.
  • P/E ratio of 45.0 suggests a premium valuation compared to some peers, indicating investor expectations of future growth.
  • Gross margin of 76.7% demonstrates strong pricing power and efficient cost of goods sold management.
  • Profit margin of 1.0% indicates potential challenges in managing operating expenses and achieving higher profitability.
  • Beta of 0.70 suggests lower volatility compared to the overall market, potentially appealing to risk-averse investors.

Who Are USNA's Competitors?

USNA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
HLF Herbalife Nutrition Ltd. $13.18 +0.53% $1.37B 94
NUS Nu Skin Enterprises, Inc. $5.03 +0.40% $244.21M 78
GPAGF Gruma, S.A.B. de C.V. $18.50 +2.21% $6.31B 66
PNGAF Pangea Wellness Inc. $0.37 +10.51% $5.54M 65
ZHYBF Zhong Yuan Bio-Technology Holdings Limited $2.02 +0.00% $35.75M 64
BOF BranchOut Food Inc. $4.58 -4.18% $70.15M 61
WYGC Wenyuan Group Corp. $0.16 -24.35% $13.22M 60
BRCNF Burcon NutraScience Corporation $1.38 +0.00% $17.57M 59

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are USNA's Key Strengths?

  • Strong brand reputation for high-quality products.
  • Global distribution network with a presence in key markets.
  • Proprietary formulations and science-based approach.
  • Direct sales network providing a competitive distribution advantage.

What Are USNA's Weaknesses?

  • Reliance on direct sales model, which can be susceptible to regulatory scrutiny.
  • Relatively low profit margin compared to some competitors.
  • Vulnerability to economic downturns affecting consumer spending.
  • Potential for negative publicity related to distributor practices.

What Could Drive USNA Stock Higher?

  • Launch of new personalized nutrition products in Q3 2026, targeting a growing segment of health-conscious consumers.
  • Expansion of the direct sales network in key Asian markets, driving revenue growth and market share.
  • Continued investment in research and development to support product innovation and differentiation.
  • Potential strategic partnerships with healthcare providers to expand distribution channels by Q4 2026.

What Are the Key Risks for USNA?

  • Rich valuation — a P/E of 45.0 runs well above the Consumer Defensive sector’s ~29x, leaving little room for a miss.
  • Regulatory scrutiny of the direct sales model and product claims could impact operations.
  • Fluctuations in raw material costs and supply chain disruptions could affect profitability.
  • Intense competition from established players and new entrants in the nutritional supplement market.
  • Changes in consumer preferences and dietary trends could impact product demand.
  • Negative publicity related to distributor practices or product safety could damage brand reputation.

What Are the Growth Opportunities for USNA?

  • Expansion in Asia Pacific: USANA has a significant opportunity to expand its presence in the Asia Pacific region, driven by increasing disposable incomes and a growing demand for health and wellness products. The Asia Pacific dietary supplements market is projected to reach $97.2 billion by 2027. By leveraging its direct sales model and tailoring products to local preferences, USANA can capture a larger share of this market over the next 3-5 years.
  • Product Innovation: Investing in research and development to introduce new and innovative products can drive revenue growth. The global nutraceuticals market is expected to reach $578.23 billion by 2025. USANA can capitalize on this trend by developing products that address specific health needs and incorporating cutting-edge scientific advancements. New product launches can attract new customers and increase sales within the next 2-3 years.
  • Online Sales Growth: Enhancing its online sales platform and digital marketing efforts can expand USANA's reach and improve customer engagement. The global e-commerce market is growing rapidly, with online sales of dietary supplements increasing significantly. By investing in user-friendly websites, mobile apps, and targeted online advertising, USANA can drive online sales growth over the next 1-2 years.
  • Strategic Partnerships: Forming strategic partnerships with healthcare providers, fitness centers, and other organizations can expand USANA's distribution network and increase brand awareness. Collaborating with established players in the health and wellness industry can provide access to new customer segments and enhance credibility. These partnerships can be established within the next year and contribute to long-term growth.
  • Personalized Nutrition: Capitalizing on the trend towards personalized nutrition can differentiate USANA from its competitors and attract health-conscious consumers. By offering customized supplement recommendations based on individual health profiles and preferences, USANA can enhance customer loyalty and drive sales. The personalized nutrition market is expected to grow significantly in the coming years, and USANA can position itself as a leader in this space within the next 3-5 years.

What Opportunities Does USNA Have?

  • Expansion in emerging markets with growing demand for health and wellness products.
  • Development of new and innovative products to address specific health needs.
  • Enhancement of online sales platform and digital marketing efforts.
  • Strategic partnerships with healthcare providers and fitness centers.

What Threats Does USNA Face?

  • Increasing competition from established players and new entrants.
  • Evolving consumer preferences and changing dietary trends.
  • Regulatory scrutiny and potential changes in labeling requirements.
  • Supply chain disruptions and fluctuations in raw material costs.

What Are USNA's Competitive Advantages?

  • Proprietary formulations and science-based approach.
  • Direct sales network providing a competitive distribution advantage.
  • Established brand reputation for high-quality products.
  • Global distribution network with a presence in key markets.

What Does USNA Do?

USANA Health Sciences, Inc., founded in 1992 and headquartered in Salt Lake City, Utah, develops, manufactures, and sells science-based nutritional and personal care products. The company's core business revolves around providing high-quality supplements, personal care items, and related products through a direct sales model. USANA's product portfolio includes USANA nutritional products, featuring essentials/CellSentials—vitamin and mineral supplements designed for various age groups, optimizers—targeted supplements addressing cardiovascular, skeletal/structural, and digestive health needs, and foods such as meal replacement shakes and snack bars. Additionally, USANA offers Celavive, a skin care regimen catering to diverse skin types and ethnicities, along with products for prenatal, infant, and young child age groups. The company supports its associates with materials and online tools to facilitate business building and product marketing. USANA operates directly in the Asia Pacific, the Americas, and Europe, leveraging both physical distribution and online channels. USANA has established research collaborations, including an agreement with Beijing University of Chinese Medicine, to further its research in traditional Chinese medicine. The company also partners with the National Sports Training Bureau.

What Products and Services Does USNA Offer?

  • Develops and manufactures science-based nutritional supplements.
  • Offers a range of vitamin and mineral supplements for various age groups.
  • Provides targeted supplements for cardiovascular, skeletal, and digestive health.
  • Produces meal replacement shakes, snack bars, and related food products.
  • Offers Celavive, a skin care regimen for different skin types and ethnicities.
  • Provides products for prenatal, infant, and young child age groups.
  • Offers materials and online tools to assist associates in building their businesses.
  • Markets products directly in the Asia Pacific, the Americas, and Europe, as well as online.

How Does USNA Make Money?

  • Direct sales through a network of independent distributors.
  • Manufacturing and selling nutritional and personal care products.
  • Online sales through the company's website.
  • Research and development of new products.

What Industry Does USNA Operate In?

USANA Health Sciences, Inc. operates within the global packaged foods industry, which is characterized by increasing demand for health and wellness products. The market is driven by rising health awareness, aging populations, and growing disposable incomes, especially in emerging economies. The competitive landscape includes major players like Herbalife Nutrition (HLF) and Nu Skin Enterprises (NUS), as well as numerous smaller companies. USANA differentiates itself through its science-based formulations, direct sales model, and global distribution network. The industry faces challenges such as evolving consumer preferences, regulatory scrutiny, and supply chain disruptions.

Who Are USNA's Key Customers?

  • Individuals seeking nutritional supplements and personal care products.
  • Health-conscious consumers.
  • Independent distributors who sell USANA products.
  • Customers in the Asia Pacific, the Americas, and Europe.
AI Confidence: 71% Updated: May 9, 2026

Net buyingInsider Activity

Over the past six months, USANA Health Sciences, Inc. insiders filed 30 SEC Form 4 transactions — 17 sales and 13 purchases. On net that is roughly 12K shares acquired (about $637K) — insiders putting money in tends to read as conviction.

USNA Valuation & Market Position

With a $398.06M market cap, USANA Health Sciences, Inc. sits in the small-cap segment of the market. Relative to its peer group, USNA's quantitative score of 78/100 is roughly in line with the peer average of 73/100.

ROE 2%Key Financial Metrics

Return on equity for USANA Health Sciences, Inc. stands at 1.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.2%, showing how much profit it generates from its asset base. USNA trades at a trailing price-to-earnings ratio of 45.04, above the Consumer Defensive sector average of ~29x. Its free cash flow yield is 0.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.51 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.2%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 8/9Financial Health

USANA Health Sciences, Inc.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.27 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2027 estForward Outlook

Wall Street analysts project USANA Health Sciences, Inc. revenue of about $945.1M for fiscal 2027, with EPS near $2.12.

Company Profile

USANA Health Sciences, Inc. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Salt Lake City, US. The company is led by CEO Kevin G. Guest. USNA has traded publicly since 1994.

USNA Financials

Fundamental Snapshot

Revenue Growth (FY)
+8.3%
Net Income Growth (FY)
-74.4%
EPS Growth (FY)
-73.6%
Free Cash Flow Growth (FY)
-83.3%
P/E (TTM)
45.0
Return on Equity (TTM)
+1.7%
Current Ratio
2.5
EV/EBITDA (TTM)
3.1

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Strong brand reputation for high-quality products.
  • Global distribution network with a presence in key markets.
  • Proprietary formulations and science-based approach.
  • Direct sales network providing a competitive distribution advantage.

Bear Case

  • Reliance on direct sales model, which can be susceptible to regulatory scrutiny.
  • Relatively low profit margin compared to some competitors.
  • Vulnerability to economic downturns affecting consumer spending.
  • Potential for negative publicity related to distributor practices.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

USNA Latest News

USNA Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for USNA.

Price Targets

Consensus target: $39.00

USNA MoonshotScore

78/100

What does this score mean?

The MoonshotScore rates USNA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Kevin G. Guest

Chief Executive Officer

Kevin G. Guest has served as the Chief Executive Officer of USANA Health Sciences, Inc. He brings extensive experience in the direct selling and nutritional supplement industries. Prior to his role as CEO, Guest held various leadership positions within USANA, including President and Chief Marketing Officer. His background includes a strong focus on sales, marketing, and international expansion. He is known for his strategic vision and commitment to innovation.

Track Record: Under Kevin Guest's leadership, USANA has focused on expanding its global presence and enhancing its product portfolio. He has overseen the implementation of new marketing strategies and the development of innovative products. During his tenure, USANA has navigated challenges related to regulatory changes and competitive pressures. He continues to focus on sustainable growth and improving operational efficiency.

What Investors Ask About USANA Health Sciences, Inc. (USNA) — Consumer Defensive

What does USANA Health Sciences, Inc. do?

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products through a direct sales model. The company's product portfolio includes vitamin and mineral supplements, targeted supplements for specific health needs, meal replacement shakes, snack bars, and skin care products. USANA operates in the Asia Pacific, the Americas, and Europe, leveraging its network of independent distributors to reach consumers. The company focuses on providing high-quality products and supporting its distributors with marketing and business-building tools.

What do analysts say about USNA stock?

Analyst coverage of USNA stock is limited, reflecting its smaller market capitalization within the consumer defensive sector. Key valuation metrics include its P/E ratio of 45.0 and its gross margin of 76.7%. Growth considerations center on its ability to expand in emerging markets, innovate its product offerings, and manage its direct sales network effectively. Investors should monitor sales growth, profitability trends, and regulatory developments to assess the company's long-term potential. Analyst consensus is Unknown.

What are the main risks for USNA?

USANA faces several key risks, including regulatory scrutiny of its direct sales model and product claims, fluctuations in raw material costs and supply chain disruptions, intense competition from established players and new entrants, and changes in consumer preferences and dietary trends. Negative publicity related to distributor practices or product safety could also damage the company's brand reputation. Effective risk management and proactive adaptation to market changes are crucial for USANA's long-term success.

What are the key factors to evaluate for USNA?

USANA Health Sciences, Inc. (USNA) holds an AI score of 78/100 (high). P/E: 45.0x vs the S&P 500's ~20-25x. Analysts target $39.00 (+81%). Not financial advice.

How frequently does USNA data refresh on this page?

USNA prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven USNA's recent stock price performance?

USANA Health Sciences, Inc. (USNA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand reputation for high-quality products. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider USNA overvalued or undervalued right now?

USANA Health Sciences, Inc. (USNA) trades at 45.0x earnings. Analysts target $39.00 (+81%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying USNA?

Before investing in USANA Health Sciences, Inc. (USNA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Analyst opinions and ratings are not available in the provided data.
Data Sources

Popular Stocks